Category Archives: announcement

Duke CTSI Announces TransPop Expansion as MURDOCK Study Celebrates 10th Anniversary

Dr. L. Kristin Newby

In conjunction with the 10th anniversary of the first participant enrolled in the landmark MURDOCK Study, the Duke CTSI Translational Population Health Research group has announced plans to double its clinical research space at the North Carolina Research Campus in Kannapolis.
Continue reading Duke CTSI Announces TransPop Expansion as MURDOCK Study Celebrates 10th Anniversary

MURDOCK Study cohort shows physical decline starts sooner than expected

MURDOCK Study cohort team

So, you think aging starts at 65? Think again. Physical decline often begins when people enter their 50s, according to data from the Physical Performance Across the Lifespan Study (PALS), a collaboration between the MURDOCK Study and Duke Claude D. Pepper Older Americans Independence Center.

Continue reading MURDOCK Study cohort shows physical decline starts sooner than expected

Social Determinants of Health

Data+ and Duke CTSI TransPop have launched Social Determinants of Health in Kannapolis, North Carolina, an initiative to bring together data that will facilitate research using social determinants of health to examine and understand health disparities. A team of seven students led by faculty are building a database of publicly available data sources in Kannapolis and Cabarrus County. MURDOCK Study investigators will be able to tap into that data, adding richness and depth to the biorepository.

Learn more

Duke launches second enrollment location for Project Baseline study

With a study watch on her wrist and a sleep sensor in her new tote bag, a Caucasian woman in her 40s walked out of the Duke University Medical Center around 5:30 p.m. Thursday, July 13 as the first participant enrolled in the Project Baseline study in Durham.

Simultaneously, Duke’s Project Baseline study team in Kannapolis, North Carolina enrolled their third participant, bringing Duke’s total enrollment to four since June 29. A day-and-a-half-long process that includes multiple health tests and donations of blood, urine, saliva, tears, and other biospecimens, enrollment will continue ramping up this summer at both the Durham and Kannapolis locations, reaching full capacity this fall.

Continue reading Duke launches second enrollment location for Project Baseline study

CTSI team enrolls first Duke participant in Project Baseline

This week, the CTSI team in Kannapolis launched the Project Baseline study in North Carolina with the enrollment of Duke’s first participant. The study is the first initiative of Project Baseline, an ambitious effort to develop a well-defined “baseline” of human health, and a rich data platform to help researchers better understand health and disease and the transitions between them.

Read more on the Duke School of Medicine blog

MURDOCK MS Study Publishes Research Findings

Physicians have long used beta interferon drugs to treat multiple sclerosis (MS), but these drugs only help about half
 of patients. Now, samples and data from the MURDOCK 
MS Study are helping researchers to better understand the difference between those who respond to beta-interferon treatment and those who do not. That could lead to alternative treatment options for people living with MS.
Continue reading MURDOCK MS Study Publishes Research Findings

New Gene Interaction Appears to be Associated with Increased MS Risk

A person carrying variants of two particular genes could be almost three times more likely to develop multiple sclerosis, according to the latest findings from scientists at Duke Health and the University of Texas Medical Branch at Galveston.

 

The research used biological samples from the MURDOCK MS Study. The finding, published in the March 23 issue of the journal Cell, could open the way for new tests to identify people who are at greatest risk of MS and autoimmune disorders, as well as the development of novel drugs, the researchers said.
Continue reading New Gene Interaction Appears to be Associated with Increased MS Risk

MURDOCK study and more